FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

83664011000036102: Stalevo 75/18.75/200 (carbidopa 18.75 mg + entacapone 200 mg + levodopa 75 mg) tablet (trade product unit of use)

Status: current, Defined. Date: 31-Mar 2010. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3728421000168110 Stalevo 75/18.75/200 tablet en Synonym Active Case sensitive Australian Medicines Terminology module
3894291000168113 Stalevo 75/18.75/200 (carbidopa 18.75 mg + entacapone 200 mg + levodopa 75 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
466480011000036119 Stalevo 75/18.75/200 (carbidopa 18.75 mg + entacapone 200 mg + levodopa 75 mg) film-coated tablet (trade product unit of use) en Fully specified name Inactive Case sensitive Australian Medicines Terminology module
466481011000036114 Stalevo 75/18.75/200 film-coated tablet en Synonym Inactive Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Stalevo 75/18.75/200 tablet has manufactured dose form tablet true Inferred relationship Some
Stalevo 75/18.75/200 tablet has intended active ingredient entacapone true Inferred relationship Some 1357362302
Stalevo 75/18.75/200 tablet has Australian BoSS carbidopa true Inferred relationship Some 1111094658
Stalevo 75/18.75/200 tablet has unit of use tablet true Inferred relationship Some 1973094047
Stalevo 75/18.75/200 tablet Is a trade product unit of use true Inferred relationship Some
Stalevo 75/18.75/200 tablet Is a Stalevo 75/18.75/200 true Inferred relationship Some
Stalevo 75/18.75/200 tablet Is a levodopa 75 mg + carbidopa 18.75 mg + entacapone 200 mg tablet true Inferred relationship Some
Stalevo 75/18.75/200 tablet has manufactured dose form film-coated tablet false Inferred relationship Some
Stalevo 75/18.75/200 tablet has intended active ingredient carbidopa true Inferred relationship Some 1111094658
Stalevo 75/18.75/200 tablet has intended active ingredient levodopa true Inferred relationship Some 1973094046
Stalevo 75/18.75/200 tablet has Australian BoSS levodopa true Inferred relationship Some 1973094046
Stalevo 75/18.75/200 tablet has Australian BoSS entacapone true Inferred relationship Some 1357362302
Inbound Relationships Type Active Source Characteristic Refinability Group
Stalevo 75/18.75/200 tablet, 10, bottle has TPUU True Stalevo 75/18.75/200 tablet Inferred relationship Some 1
Stalevo 75/18.75/200 tablet, 30, bottle has TPUU True Stalevo 75/18.75/200 tablet Inferred relationship Some 1
Stalevo 75/18.75/200 tablet, 100 has TPUU True Stalevo 75/18.75/200 tablet Inferred relationship Some 1
Stalevo 75/18.75/200 tablet, 10 has TPUU True Stalevo 75/18.75/200 tablet Inferred relationship Some 1
Stalevo 75/18.75/200 tablet, 30 has TPUU True Stalevo 75/18.75/200 tablet Inferred relationship Some 1
Stalevo 75/18.75/200 tablet, 100, bottle has TPUU True Stalevo 75/18.75/200 tablet Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start